Myeloproliferative neoplasms trials in Spain

28 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

  Where

  Badalona, Barcelona, Madrid, Salamanca, Valencia, Zaragoza

  Age

  18 years and over

  People

  135 worldwide

  Run by

  Takeda

  See details and how to joinNCT05037760 · EU 2023-507468-38-00
• Phase 3Taking people
  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  Where

  Badalona, Barcelona, Cáceres, Las Palmas de Gran Canaria, Madrid, Málaga, Salamanca, Valencia, Zaragoza

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Kartos Therapeutics, Inc.

  See details and how to joinNCT06479135
• Phase 1/2Taking people
  Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

  Where

  Lleida, Madrid, Málaga, Zaragoza

  Age

  18 years and over

  People

  70 worldwide

  Run by

  Telios Pharma, Inc.

  See details and how to joinNCT05280509